Patent ID: 11866446
Assignee: VERTEX PHARMACEUTICALS INCORPORATED
Field: Organic fine chemistry (Chemistry)
Classification: CPC C  A | IPC C

Claim 13:
14. The compound, tautomer, deuterated derivative, or pharmaceutically acceptable salt according to claim 1, wherein R5 is selected from C1-C2 alkyl, C(═O)O(C1-C2 alkyl), cyclopropyl, cyclobutyl, and 5- to 6-membered heterocyclyl; wherein:
the C1-C2 alkyl of R5 is optionally substituted with 1 to 3 groups independently selected from F, Cl, Br, cyano, —OH, and C1-C2 alkoxy; and
the cyclopropyl, the cyclobutyl, and the 5- to 6-membered heterocyclyl of R5 are each optionally substituted with 1 to 3 groups independently selected from F, Cl, Br, cyano, —OH,, C1-C2 alkyl, and C1-C2 alkoxy.